Dr. Jeffrey Becker

Jeffrey Becker, MD directs development of next generation psychedelic and ketamine formulations for precision medical treatments as the Chief Scientific Officer of Bexson Biomedical. He has over 20-years of research and clinical experience with ketamine as one of the first MDs in the U.S. administering it for depression. He has trained many clinicians in ketamine assisted psychotherapy, and is a world recognized speaker mapping the mechanisms and meaning in ketamine and psychedelic transcendence. He trained at UCLA/NPI in both Medicine and Psychiatry, with a focus on Neuropsychiatry and Functional Medicine. He is board-certified in Psychiatry and Neurology, and Integrative and Holistic Medicine.